1. Home
  2. QS vs RGEN Comparison

QS vs RGEN Comparison

Compare QS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuantumScape Corporation

QS

QuantumScape Corporation

HOLD

Current Price

$5.96

Market Cap

7.5B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$111.82

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QS
RGEN
Founded
2010
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5B
8.1B
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
QS
RGEN
Price
$5.96
$111.82
Analyst Decision
Sell
Buy
Analyst Count
7
11
Target Price
$8.40
$175.64
AVG Volume (30 Days)
8.9M
834.9K
Earning Date
04-22-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
19.15
286.96
EPS
N/A
0.86
Revenue
N/A
$141,236,000.00
Revenue This Year
N/A
$14.31
Revenue Next Year
$1,827.70
$14.41
P/E Ratio
N/A
$128.20
Revenue Growth
N/A
35.10
52 Week Low
$3.40
$102.97
52 Week High
$19.07
$175.77

Technical Indicators

Market Signals
Indicator
QS
RGEN
Relative Strength Index (RSI) 31.18 32.82
Support Level $4.21 N/A
Resistance Level $7.21 $130.56
Average True Range (ATR) 0.32 4.57
MACD 0.01 0.42
Stochastic Oscillator 4.70 13.32

Price Performance

Historical Comparison
QS
RGEN

About QS QuantumScape Corporation

QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles and other applications. The company's solid-state lithium-metal battery technology is designed to offer greater energy density, faster charging, and enhanced safety. Its battery cells have none of the host materials used in conventional anodes.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: